HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diagnostic, Prognostic, and Predictive Role of Next-Generation Sequencing in Mature Lymphoid Neoplasms.

Abstract
Lymphoma is a clinically and biologically heterogeneous disease. Next-generation sequencing (NGS) has expanded our understanding of this heterogeneity at the genetic level, refining disease classification, defining new entities, and providing additional information that can be used in diagnosis and management. This review highlights some of the NGS findings in lymphoma and how they can be used as genetic biomarkers to aid diagnosis and prognosis and guide therapy.
AuthorsGraham W Slack
JournalSurgical pathology clinics (Surg Pathol Clin) Vol. 16 Issue 2 Pg. 433-442 (Jun 2023) ISSN: 1875-9157 [Electronic] United States
PMID37149368 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2023 Elsevier Inc. All rights reserved.
Topics
  • Humans
  • Mutation
  • Prognosis
  • Lymphoma (diagnosis, genetics, pathology)
  • High-Throughput Nucleotide Sequencing

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: